Abstract
Objective
To evaluate mid‐ to long‐term results of revision total hip arthroplasty for massive femoral bone loss using a cementless modular, fluted, tapered stem.
Methods
This is a retrospective study performed at a single hospital. During the period of January 2007 to January 2015, 33 patients (34 hips) underwent primary revision surgery with cementless modular, fluted, tapered stems due to femoral bone loss. Sixteen men and 17 women were included in the study, with an average age of 63.9 ± 11.7 years (range, 27 to 88 years). Operative data including operative duration, length of incision, drainage volume and duration, blood loss and transfusion, cases of bone graft and extended trochanteric osteotomy were recorded. Clinical evaluation was performed using Harris hip score (HHS), visual analogue scale (VAS), and patients' satisfaction. Radiographic data including femoral stem fixation, subsidence, integrin of allograft bone, and leg length discrepancy were assessed. Complications and survivorship were evaluated using Kaplan–Meier survival rate.
Results
The mean follow‐up was 9.1 ± 2.5 years (range, 5–13 years). The Harris hip score was 43.6 ± 11.5 preoperatively and maintained at 86.5 ± 6.6 at the time of latest follow‐up (P < 0. 05). The X‐ray showed bone ingrowth fixation in 30 hips (88%), fibrous stable fixation in three hips (9%), and instability in one hip (3%). The average stem subsidence was 3.9 ± 2.2 mm (range, 1 to 10 mm). The mean difference in leg length in our study was 3.3 ± 2.7 mm (range, 0 to 10 mm), and the leg length discrepancy in 28 (82%) patients was within 5 mm. No case of junction fracture was observed. Seven (21%) intraoperative fractures occurred in our study. Three (9%) cases with infection were observed after revision. Six (18%) patients had lower limb vein thrombosis. The survivorship of prostheses with re‐revision for any reason was 95% (95% CI, 12.0 to 13.0) at the 10‐year follow‐up. Three (9%) re‐revisions were needed, including one for aseptic loosening, one for dislocation, and one for infection.
Conclusion
The mid‐ to long‐term results of revision total hip arthroplasty with the cementless modular, fluted, tapered stems are encouraging for massive femoral bone loss.
Keywords: Bone loss, Revision, Total hip arthroplasty
The mid‐ to long‐term outcomes of revision total hip arthroplasty with the cementless modular, fluted, tapered stem are inspiring for massive proximal femoral bone defects.

Introduction
Over the past few decades, the number of revision total hip arthroplasty (RTHA) procedures performed has gradually increased following the large cohort of total hip arthroplasties (THAs) 1 . Furthermore, it has been predicted that the demand for RTHAs will be dramatically amplified by over 137% worldwide by 2030 2 , 3 , 4 , 5 . Aseptic loosening and peri‐prosthetic fracture are two common causes of failed THA 6 , which are triggered by the accumulation of wear particles at the peri‐prosthesis area for initiation of osteolysis 7 . Sustained osteolysis around the implant triggers massive bone loss and therefore fails to compress and solidly fix the implant 8 . Bone loss remains one of the biggest technical challenges in RTHA. In such a situation, RTHA is required to reconstruct damaged bone and restore the bone stock.
A variety of strategies have been applied to treat femoral bone loss in RTHA. Long cemented stems for aseptic loosening in elderly patients permit early weight bearing and show promising clinical and radiographic outcomes 9 . Long tapered hydroxyapatite‐coated stems can provide stable fixation, bone integration, and reduce stress shielding. However, these stems are suitable for patients with Paprosky I and II defects who had good proximal femoral bone stock 10 . In addition, cylindrical stems have been considered as the standard used in revision with femoral bone defects for many years, while increased failure of ingrowth and loosening has been commonly reported 11 . Moreover, monoblock tapered stems were involved in regeneration of proximal femoral bone following revision THA and reported satisfactory clinical outcomes 12 , 13 . Also, impaction bone grafting is another strategy to reliably restore bone loss in RTHA 14 . Nevertheless, the effect of these reconstruction techniques is limited in massive femoral bone defects or unsatisfactory for long‐term results 15 , 16 , 17 .
Cementless modular, fluted, tapered stems are another option for massive femoral bone defects in RTHA 18 and exhibit several beneficial characteristics. For example, the tapered distal design is easier to engage a short isthmic segment compared with cylindrical distal geometry 11 ; moreover, the modular design allows adjustment of the leg length, anteversion and offset to optimize stability and reduce the potential risk of dislocation for specific patients 19 . Furthermore, the grit‐blasted titanium surface facilitates bone growth and attenuates thigh pain and stress shielding 20 . However, concerns about junctional fractures of the modular stem have been raised and reported by a few authors 21 , 22 . Several studies of RTHA with modular, fluted, tapered stems obtained good results at short‐ to mid‐term follow‐up 23 , 24 , 25 . However, few reports of the long‐term results of these prostheses are available, and survivorship of the junction of the modular stem is worth further investigation.
Therefore, in this study we followed up patients who underwent RTHA using cementless modular, fluted, tapered stem for femoral bone loss. The purpose of this retrospective study was: (i) to evaluate the mid‐ to long‐term clinical and radiographic results of modular, fluted, tapered, stem in massive bone defect RTHA; (ii) to determine the complications in these complex patients with massive bone loss; and (iii) to investigate the long‐term survivorship of the junction of the modular stem.
Materials and Methods
Inclusion and Exclusion Criteria
Inclusion criteria were: (i) revision THA with bony defects of the proximal femur classified as Paprosky 26 type II–IV or Vancouver 27 type B2–B3; (ii) patients who underwent primary RTHA with femoral bone loss using LINK MP cementless modular, fluted, tapered stem (Waldemar Link, Hamburg, Germany); (iii) all revision‐bearing surfaces were ceramic‐on‐ceramic (CoC); and (iv) all RTHAs were performed by one single, experienced orthopaedic surgeon.
Exclusion criteria were: (i) all kinds of tumors or secondary neoplasia diseases; (ii) patients with prosthetic joint infection (PJI); (iii) patients with severe underlying diseases or cardiopulmonary dysfunction graded as New York Heart Association (NYHA) classification IV and American Aociety of Anaesthesiologists (ASA) classification IV; and (iv) patients who underwent re‐revision THA.
General Characteristics of Participants
This retrospective study was performed with the approval of the institutional ethics committee. From January 2007 to January 2015, 40 patients underwent RHTA with femoral bone defects. After application of exclusion criteria, 37 patients were eligible for review. However, four patients were lost to follow‐up within 5 years after surgery. Therefore, we ultimately enrolled 33 consecutive patients (34 hips) with femoral bone defects after primary THA (Fig. 1).
Fig. 1.

Flowchart of patient selection in the present study.
Operative Techniques
Step 1: All operations were performed using general anesthesia. The patient was placed in the lateral position with adduction and internal rotation of the affected hip joint. The perineum was protected using non‐woven fabric. The skin of the whole leg and feet was disinfected and sterile drapes were placed on the operation side.
Step 2: The posterolateral approach was performed along the previous incision in all operations. We sequentially cut the skin, subcutaneous tissue, incised the fascia lata and bluntly dissected the gluteus maximus. Then, the gluteus medius was identified and forward retracted, followed by abduction and external rotation of the hip to expose the gluteus minimus and piriformis. The tendon of piriformis was incised after being marked by suture. Next, we dissected short external rotators and hip capsule to expose the artificial joint. Finally, we dislocated the hip joint by flexion, adduction, and internal rotation of the hip.
Step 3: Then, the loosened implant was extracted. Damaged bone, callus, and scar tissues could be observed. The residual tissues in the femoral canal and acetabulum were debrided completely. At the same time, the removed tissue was tested for pathology and bacteriology. The extended trochanteric osteotomy (ETO) was performed in situ 28 , such as severe femoral prosthesis subsidence or extensive femoral proximal osteolysis to avoid trochanteric fracture and eccentric reaming.
Step 4: After revision of the acetabulum, we prepared the femoral canal for implantation using hand reaming. Then, we applied trial segments in a satisfactory position to optimize the leg length, anteversion, and soft tissue tension. Finally, the prosthesis was implanted.
Step 5: Hip joint activities were tested again; if there was no risk for dislocation, the incision was closed and bandaged under pressure. In addition, cerclage wires, structural autografts, or allografts were used for femoral reconstruction.
Surgical diagrams of revision total hip arthroplasty are shown in Fig. 2.
Fig. 2.

Revision total hip arthroplasty surgical diagrams of the key procedure. (A) The posterolateral approach was performed along the previous incision; (B) The utilization of extended trochanteric osteotomy (ETO); (C) The residual tissues were debrided and tested for pathology and bacteriology; (D) The cerclage wires were used for femoral reconstruction.
Rehabilitation
The methods of enhanced recovery after surgery were applied to permit patients to recover faster and more effectively 29 . Tranexamic acid was used before and after surgery to reduce blood loss, and the drainage tube was removed within 48 h after the surgery. Routine anticoagulant therapy was applied for at least 14–35 days to prevent lower limb deep vein thrombosis (DVT). Physical therapists guided patients to exercise muscle strength and passive knee motion on the same day after surgery. Under the supervision of the physical therapist, they started to exercise actively, stand at the side of the bed, and walk with a walker twice daily for 30 min each time. Full weight‐bearing with a walker was required for 6 weeks.
Clinical and Radiographic Evaluation
Massive Femoral Bone Loss Quantification
The quantitative evaluation of femoral bone loss was based on the area of femoral bone loss, quality of remaining support bone stocks, and stability of femoral component. The evaluation was classified as following: mild: minimal proximal metaphyseal bone loss with diaphysis cortical bone intact, and the femoral component is stable; mid: moderate absent proximal metaphyseal bone loss with diaphysis cortical bone intact, and the stem is loose; massive: severe absent proximal metaphyseal bone loss with diaphysis cortical bone absent at different degrees, and the stem is markedly loose.
Harris Hip Score (HHS)
The HHS 30 was used to evaluate the function of hip pre‐ and postoperatively. The HHS evaluation system consists of four parts: pain, function, absence of deformity, and range of motion. The maximum HHS was 100 points (the higher the score, the better the outcome). The clinical significance of these scores was graded as following: <70 poor; 70–80 fair; 80–90 good; and 90–100 excellent.
Visual Analogue Scale (VAS)
The VAS score 31 was used to evaluated the degree of hip joint pain pre‐ and postoperatively. The degree of hip joint pain was assessed using a visual analogue graduated scale from 0 to 10 points (no pain to extreme pain). The clinical significance of these scores was graded as following: 0: no pain; 1–3: mild pain, tolerable; 4–6: moderate pain, mild affected sleep, still tolerable; and 7–10: severe, unbearable pain, affected appetite, and unable to sleep.
Complications
Major complications including intraoperative fracture, infection, thrombosis, dislocation, ETO non‐union, aseptic loosening, peri‐prosthesis fracture, and modular junction fracture were recorded. Any re‐revisions related to the revision hips were also recorded.
Fixation of Femoral Stem
The standard anteroposterior view of the bilateral hip and lateral view of the operative hip were taken for each patient. All imaging data were displayed and measured via the picture archiving and communication system (PACS, Neusoft Medical Information System, Shenyang, China). All radiographs were measured by two observers who were blinded to the patients' recovery. The femoral stem fixation was used to evaluate the stability of inserted prosthesis. The classification of femoral stem fixation 32 was graded as following: stable: formation of new bone in porous areas with no radiolucent lines; fibrous stable: no progressive subsidence of prosthesis or extensive radiolucent lines; unstable: obvious subsidence and varus of prosthesis with extensive radiolucent lines and sclerosis.
Subsidence of Femoral Stem
The range of subsidence of the femoral stem was used to evaluate the survivorship of the prosthesis. The subsidence was assessed using the distance from the tip of the greater trochanter to the stem shoulder 33 . The degree of stem subsidence exceeding 5 mm was considered significant 34 .
Stress Shielding
The stress shielding effect was used to evaluate the bone defect of proximal femur. The stress shielding was assessed by thickness of cortical bone and bone density. It was divided into four levels according to the Engh zones 35 : level 0: no bone absorption was observed; level I: bone absorption was observed in one to four zones; level II: bone absorption was observed in five to seven zones; bone absorption was observed in more than eight zones.
Restoration of Bone and Integrin of Allograft Bone
The restoration of bone and integrin of allograft bone were used to evaluate the quality of bone reconstruction. Restoration of bone was calculated by the ratio of the width of the cortical bone to its outside diameters, which was measured at 1 cm distal to the inferior margin of the lesser trochanter 36 . The integrin of allograft bone was judged by the trabeculae between the grafted and host bones 37 .
Leg Length Discrepancy
The discrepancy of leg length was used to evaluate the recovery of patients related to back pain and gait correction. The discrepancy was assessed using the perpendicular distance from the tip of the lesser trochanter to the teardrop line. The leg length discrepancy was required to correct to within 10 mm 38 .
Statistical Analysis
IBM SPSS 25.0 (International Business Machines, Armonk, New York, USA) was used for statistical analysis. Continuous variable data obeyed a normal distribution, and the mean and standard deviation were determined for each measurement, shown as (−x ± s). Additionally, the 95% confidence interval, range, and percentage were calculated for partial data. Data between two groups were statistically analyzed with the use of an independent‐sample t test. A Kaplan–Meier analysis was used to assess survivorship. P values of <0.05 were considered significantly significant.
Results
Demographic Data
There were 17 male and 16 female patients with an average age of 63.9 ± 11.7 years (range, 27 to 88) in this study (Table 1). The primary THA indications included osteoarthritis, femoral head necrosis, femoral neck fracture, developmental dysplasia of the hip (DDH), and ankylosing spondylitis. Among these patients, 27 (79%) were Paprosky types II, III, and IV, and seven (21%) were Vancouver types B2 and B3 (Figs 3 and 4). The mean body mass index (BMI) was 23.7 ± 3.7 kg/m2 (range, 18 to 31 kg/m2). There were four patients lost to follow‐up, the follow‐up rate was 89.2% (33 patients). The minimum follow‐up was 5 years (mean 9.1 years; range, 5 to 13 years). The follow‐up of 14 (41%) patients exceeded 10 years.
TABLE 1.
Demographic data
| Parameter | Value |
|---|---|
| Age* (year) | 63.9 ± 11.7 (range, 27 to 88) |
| Height* (cm) | 161.7 ± 7.9 (range, 140 to 180) |
| Weight* (kg) | 62.0 ± 10.1 (range, 46 to 80) |
| Body mass index* (kg/m2) | 23.7 ± 3.7 (range, 18 to 31) |
| Side† (n = 34) | |
| Left | 18 (53%) |
| Right | 16 (47%) |
| Sex† (n = 33) | |
| Female | 16 (48%) |
| Male | 17 (52%) |
| Primary THA indication† | |
| Osteoarthritis | 8 (24%) |
| Femoral head necrosis | 6 (18%) |
| Femoral neck fracture | 10 (29%) |
| Developmental Dysplasia of the Hip | 7 (21%) |
| Ankylosing spondylitis | 2 (6%) |
| Else ‡ | 1 (3%) |
| Interval period from THA to RTHA† | 9.9 ± 3.3 (range, 2 to 16) |
| Diagnosis† (n = 34) | |
| Loosening | 27 (79%) |
| Peri‐prosthesis fracture | 7 (21%) |
| Paprosky classification† | |
| II | 7 (21%) |
| IIIA | 11 (31%) |
| IIIB | 7 (21%) |
| IV | 2 (6%) |
| Vancouver classfication | |
| B2 | 3 (9%) |
| B3 | 4 (12%) |
| Mean follow‐up* | 9.1 ± 2.5 (range, 5 to 13) |
The values are given as the mean and the standard deviation, with the range in parentheses.
The value is given as the number of hips, with the percentage in parentheses.
Else: acetabulum fracture.
Fig. 3.

Radiographs of a 56‐year‐old woman who underwent hip revision 4 years after THA. (A) Radiograph before revision, showing a loosened cemented stem. (B) Postoperative radiograph with the MP Link modular prosthesis. (C) Radiograph at 10 years postoperatively. The patient obtained a good clinical outcome with no subsidence of the stem.
Fig. 4.

Radiographs of a 60‐year‐old man who underwent hip revision 8 years after THA. (A) Radiograph before revision, showing a peri‐prosthesis fracture. (B) Postoperative radiograph with a plate and cerclage wire. (C) Radiograph at 1 year postoperative. (D) Radiograph at 3 years postoperative. (E) Radiograph at 5 years postoperative. (F) Radiograph at 8 years postoperative.
General Results
During surgery, the mean operative duration was 187.2 ± 63.9 min (range, 113–335 min, Table 2). The mean length of incision was 19.4 ± 5.2 cm (range, 10–30 cm). Twenty out of 27 (74%) patients received bone graft in Paprosky group, and all patients in Vancouver group used bone graft. ETO was performed for 10 (37%) patients in Paprosky group (Fig. 5). Moreover, auxiliary fixations, including plates, single cortical screws, or cerclage wires were applied in 10 (37%) and six (86%) cases in Paprosky and Vancouver groups, respectively. After surgery, the drainage volume and duration were recorded. The mean drainage volume was 164.9 ± 122 mL (range, 11–580 mL). The mean drainage duration was 52.9 ± 11.4 h (range, 24–72 h). In addition, the mean hospital stay was 15.4 ± 6.2 days (range, 7–37 days).
TABLE 2.
Operative data
| Parameters | Paprosky II/III/IV | Vancouver B2/B3 | Total |
|---|---|---|---|
| Operative Duration* (min) | 192.9 ± 70.1 (range,115 to 335) | 165.3 ± 21.8 (range,132 to 189) | 187.2 ± 63.9 (range,113 to 335) |
| Length of Incision* (cm) | 19.5 ± 5.2 (range, 10 to 28) | 18.9 ± 5.2 (range, 14 to 30) | 19.4 ± 5.2 (range, 10 to 30) |
| Drainage Volume* (mL) | 164.5 ± 134 (range, 11 to 580) | 166.4 ± 63.9 (range, 90 to 260) | 164.9 ± 122 (range, 11 to 580) |
| Drainage Duration*(h) | 53.3 ± 12.2 (range, 24 to 72) | 51.4 ± 9.1 (range, 48 to 72) | 52.9 ± 11.4 (range, 24 to 72) |
| Blood loss (mL) | 1129 ± 734 (range,200 to 3000) | 842.9 ± 287 (range,400 to1200) | 1070 ± 673 (range,200 to3000) |
| Blood transfusion (mL) | 948.1 ± 735 (range, 0 to 2900) | 521.4 ± 376 (range, 0 to 950) | 860.3 ± 694 (range, 0 to 2900) |
| Bone graft† | 20 (74%) | 7 (100%) | 27 (79%) |
| ETO† | 10 (37%) | 0 (0%) | 10 (29%) |
| Auxiliary fixation†,‡ | 10 (37%) | 6 (86%) | 16 (47%) |
| Hospital Stay* (days) | 15.6 ± 6.3 (range, 7 to 37) | 15.0 ± 6.2 (range, 9 to 28) | 15.4 ± 6.2 (range, 7 to 37) |
The value is given as the mean and the standard deviation, with the range in parentheses.
The value is given as the number of hips, with the percentage in parentheses.
Auxiliary fixation: plates, single cortical screws or cerclage wires.
Fig. 5.

Radiographs of a 66‐year‐old female who underwent hip revision 10 years after THA. (A) Radiograph before revision, showing a loosened cementless stem. (B) Postoperative radiograph with the use of ETO. (C) Radiograph at 5 years postoperative. (D) Radiograph at 10 years postoperative.
Harris Hip Score (HHS)
Clinical evaluation showed that the HHS improved significantly from an average of 43.6 points (range, 17 to 67) preoperatively to 86.5 points (range, 67 to 97) at the last follow‐up in all patients, which showed a significant difference with a mean HHS improvement of 42.9 (P < 0.01) (Table 3). With respect to the comparison of pre‐ and postoperative HHS between the prosthesis loosening group and peri‐prosthesis fracture group by the criteria of Paprosky and Vancouver, we found that the postoperative functional results were similar in patients of both groups.
TABLE 3.
Clinical data at preoperative and mean 9.1 years postoperative
| Parameters | Preop.* | Postop.* | P value | |||
|---|---|---|---|---|---|---|
| Paprosky II/III/IV | Vancouver B2/B3 | Paprosky II/III/IV | Vancouver B2/B3 | Preop.* | Postop.* | |
| HHS score†(points) | 43.6 (17 to 67) | 86.5 (67 to 97) | 0.001 | |||
| Overall | [39.6 to 47.6] | [84.2 to 88.8] | ||||
| Pain |
17.4 (0 to 30) [14.8 to 20.0] |
18.6 (10 to 20) [15.1 to 22.1] |
41.4 (30 to 44) [39.6 to 43.2] |
41.1 (40 to 44) [39.3 to 43.0] |
0.66 | 0.89 |
| Function |
21.6 (10 to 35) [19.2 to 24.0] |
18.6 (10 to 25) [13.4 to 23.7] |
38.1 (30 to 45) [36.7 to 39.5] |
39.7 (38 to 40) [39.0 to 40.4] |
0.25 | 0.247 |
| Deformity |
2.5 (1 to 4) [2.2 to 2.7] |
2.7 (1 to 3) [2.0 to 3.4] |
3.4 (2 to 5) [3.2 to 3.7] |
3.6 (3 to 4) [3.1 to 4.1] |
0.42 | 0.54 |
| Activity |
2.6 (1 to 4) [2.3 to 2.9] |
2.0 (1 to 3) [1.5 to 2.5] |
3.2 (2 to 4) [3.1 to 3.5] |
3.1 (3 to 4) [2.8 to 3.5] |
0.046 | 0.53 |
| Subtotal |
44.1 (17 to 67) [39.2 to 48.9] |
41.9 (30 to 50) [34.3 to 49.4] |
86.2 (67 to 97) [83.4 to 89.1] |
87.6 (85 to 92) [85.0 to 90.1] |
0.66 | 0.64 |
| VAS score†(points) | 7.1 (6 to 10) | 1.1 (0 to 3) | 0.36 | |||
| Overall | [6.8 to 7.5] | [0.8 to 1.4] | ||||
| Subtotal |
7.1 (6 to 9) [6.7 to 7.5] |
7.3(6 to 8) [6.6 to 8.0] |
1.1 (0 to 3) [0.8 to 1.5] |
1.0 (0 to 2) [0.5 to 1.5] |
0.66 | 0.18 |
| Satisfaction (no. of hips)‡ | ||||||
| Satisfeid | — | — | 24 (89%) | 7 (100%) | ‐ | ‐ |
| General | — | — | 3 (11%) | 0 (0%) | ‐ | ‐ |
| Dissatisfied | — | — | 0 (0%) | 0 (0%) | ‐ | ‐ |
Preop., preoperative; Postop., postoperative; HHS, Harris Hip score; VAS, visual analogue scale.
The value is given as the mean, with the range in parentheses and the 95% CI in brackets.
The values are given as the number of hips, with the percentage in parentheses.
Visual Analogue Scale (VAS)
Consistently, the VAS scores for these patients decreased from a mean preoperative 7.1 points (range, 6 to 9) to 1.1 points (range, 0 to 3) postoperatively, with a mean VAS score decrease of 6.0. There was no significant difference in the mean VAS scores between the Paprosky and Vancouver group.
Satisfaction
Twenty‐four (89%) patients in the Paprosky group felt satisfied with the surgery, while all seven (100%) patients in the Vancouver group felt satisfied. No patients were disappointed with the RTHA.
Complications
Overall, we observed that three (9%) intraoperative fractures happened when the LINK stem was inserted, and four (12%) fractures occurred during the removal of the initial stem (Table 4). All fractures were treated with plates, single cortical screws, or cerclage wires for stable fixation. Three (9%) cases with infection were observed after revision, of which one case was treated by intravenous antibiotics and debridement, one case was treated by the vacuum sealing drainage (VSD) method, and one case needed re‐revision. Three (9%) patients in the Paprosky group and three (9%) patients in the Vancouver group had lower limb vein thrombosis, which was successfully treated by routine anticoagulant therapy. One (3%) patient in the Vancouver group was observed with artery thrombosis, which was treated with a strainer. One (3%) dislocation case happened in the Paprosky group, and re‐revision was needed for reduction. No non‐union ETO occurred in either group. One (3%) case of aseptic loosening took place 5 years after revision.
TABLE 4.
Complications
| Parameters | Paprosky II/III/IV | Vancouver B2/B3 | Total |
|---|---|---|---|
| Intraoperative fracure† | |||
| Inserting stem | 2 (7%) | 1 (14%) | 3 (9%) |
| Removing stem | 3 (11%) | 1 (14%) | 4 (12%) |
| Infection† | 2 (7%) | 1 (14%) | 3 (9%) |
| Thrombosis† | |||
| Vein | 3 (11%) | 3 (43%) | 6 (18%) |
| Artery | 0 (0%) | 1 (14%) | 1 (3%) |
| Dislocation† | 0 (0%) | 1 (14%) | 1 (3%) |
| ETO nonunion† | 0 (0%) | 0 (0%) | 0 (0%) |
| Postop. Peri‐prosthesis fracture† | 0 (0%) | 0 (0%) | 0 (0%) |
| Aseptic loosening† | 1 (4%) | 0 (0%) | 1 (3%) |
| Modular junction Fracture† | 0 (0%) | 0 (0%) | 0 (0%) |
ETO, extended trochanteric osteotomy; Postop., postoperative.
The value is given as the number of hips, with the percentage in parentheses.
Fixation of Femoral Stem
Radiographic evaluation demonstrated that 30 (88%) femoral stems remained stable, while three (9%) stems attained stable fibrous fixation. Moreover, one (3%) stem displayed unstable fixation (Table 5). The integrin of allograft bone was satisfactory with enough osteointegrin in all cases.
TABLE 5.
Radiographic data
| Parameters | Paprosky II/III/IV | Vancouver B2/B3 | Total |
|---|---|---|---|
| Femoral stem fixation† | |||
| Stable | 25 (92%) | 5 (71%) | 30 (88%) |
| Fibrous fixation | 1 (4%) | 2 (29%) | 3 (9%) |
| Unstable | 1 (4%) | 0 (0%) | 1 (3%) |
| Subsidence* | 3.8 ± 2.4 (range, 1 to 10) | 4.1 ± 1.8 (range, 2 to 7) | 3.9 ± 2.2 (range, 1 to 10) |
| ≤5 mm | 22 (81%) | 6 (86%) | 28 (82%) |
| >5 mm | 5 (19%) | 1 (14%) | 6 (18%) |
| Integrin of allograft bone† | 27 (100%) | 7 (100%) | 34 (100%) |
| Leg length discrepancy*(mm) | 2.7 ± 2.4 (range, 0 to 10) | 5.7 ± 2.7 (range, 1 to 9) | 3.3 ± 2.7 (range, 0 to 10) |
| ≤5 mm | 24 (89%) | 4 (57%) | 28 (82%) |
| >5 mm | 3 (11%) | 3 (43%) | 6 (18%) |
The values are given as the mean and the standard deviation, with the range in parentheses.
The value is given as the number of hips, with the percentage in parentheses.
Subsidence of Femoral Stem
For the range of femoral stem subsidence, the mean subsidence of all stems was 3.9 ± 2.2 mm (range, 1 to 10 mm). Of these, five (19%) stems in the Paprosky group and one (14%) stem in the Vancouver group subsided over 5 mm, but all subsidence stabilized after 1 year without further progression.
Stress Shielding
In addition, one out of 34 stems (3%) developed severe stress shielding accompanied by thigh pain, which required nonsteroidal anti‐inflammatory drugs (NSAIDs) for relief.
Leg Length Discrepancy
The averaged leg length discrepancy in all patients was 3.3 ± 2.7 mm (range, 0 to 10 mm). Three (11%) patients in the Paprosky group and four (43%) patients in the Vancouver group experienced a discrepancy of leg length over 5 mm, and we attempted to correct all cases within 10 mm.
Survivorship
During the follow‐up, three (9%) re‐revisions were needed, including one for aseptic loosening, one for dislocation, and one for infection. There was no modular junction fracture in our study. As shown in Fig. 6, the overall cumulative Kaplan–Meier survivorship with re‐revision for any reason as the end‐point was 95% at 10 years after surgery and 74% (95% CI, 12.0 to 13.0) at 13 years follow‐up. The subgroup analysis of Kaplan–Meier survivorship is shown in Fig. 6.
Fig. 6.

(A) Kaplan–Meier overall survival rate. (B) Kaplan–Meier survival rate according to the classification (Paprosky & Vancouver).
Discussion
Revision THA with massive bone defects indicates a complex challenge to perform and reconstruct the bone stock. Numerous different designs of prostheses, including cemented stems 9 , uncemented long stems 10 , cylindrical stems 11 , and monoblock tapered stems 12 , have been applied to treat this problem during RTHA. For Paprosky types I and II bone defects, these strategies have been associated with acceptable long‐term results; however, for severe bone loss, such as Paprosky type IIIA, IIIB, and IV, and Vancouver types B2 and B3, modular, fluted, tapered stems were considered to have the potential advantage of achieving long‐term fixation 17 . In our study, we focused on the strategy of the LINK MP stem, which has exhibited satisfactory short‐ to mid‐term results in previous studies 25 , 39 , 40 , whereas the long‐term results in functional restoration, pain relief, complications, and survivorship of stem have been less frequently reported.
Clinical Evaluation
HHS is the major tool used to evaluate the clinical outcome of hip surgery and incorporates dimensions of pain, function, deformity, and activity 30 . The pain and function scores contribute to over 90% of the HHS, which required doctors not only to focus on the surgery but also to manage the patients during the whole perioperative period, from the preoperative plan to rehabilitation. In our study, the average HHS after RTHA improved dramatically and reached 86.5 points at the last follow‐up, which is higher than that in previous studies, with 77 and 78 points at the latest follow‐up 38 , 39 . We believe that the better functional outcomes in our study were associated with adequate reconstruction of extensive bone defects, reduced intervention in muscular attachments of the hip, the use of ceramic‐to‐ceramic surfaces in all patients and emphasized rehabilitation to enhance patient recovery after surgery.
The leg length discrepancy is vital for patients during the process of functional recovery and is related to back pain 41 and gait correction 42 . Weiss et al. showed that 33 (52%) patients had leg length discrepancies greater than 5 mm, and even two (3%) of these patients had leg length diversity over 30 mm 39 . Restrepo et al. demonstrated that leg length was corrected within 5 mm in 95 (78%) of the patients 38 . The mean difference in leg length in our study was 3.3 mm (range, 0 to 10), and the leg length discrepancy in 28 (82%) patients was within 5 mm, which was better than previous results. The balance of both leg lengths intraoperatively could be adjusted by modular stem, which was an important advantage of the modular design.
Intraoperative Results
Intraoperative femoral fracture was not uncommon during RTHA. Wang et al. observed that 10 out of 58 (17%) intraoperative femoral fractures happened during RTHA, which might be attributed to their lack of use of extended trochanteric osteotomy (ETO) 25 . ETO was reported to decrease the potential risk of intraoperative fracture during RTHA 43 . In addition, Ovesen et al. revealed that four (3%) fractures were detected intraoperatively 24 . Brown et al. showed that four out of 58 (7%) patients had intraoperative femoral fracture due to severe bone loss without adequate supportive bone 18 . The percentage of intraoperative femoral fracture in our research was 21%, which was higher than the proportion in previous studies. Consequently, more attention should be paid to prevent fracture during RTHA, for example, reaming by hand to centralize within the canal. Moreover, cerclage wire was considered a useful tool to protect the intact femur and avoid fracture. Furthermore, an appropriate stem size with routine fluoroscopy was helpful to reduce the risk of fracture intraoperatively.
Most patients in our study sustained bone grafting, which was beneficial for large metaphyseal bone loss to improve bone regeneration. In contrast, Wang et al. illustrated that none of their patients received bone grafts, and no patients had fatigue junction fractures during 3–7 years of follow‐up 25 . However, we still suggest that bone grafts should be applied to patients with massive bone defects during RTHA to accelerate new bone formation and provide adequate support for implants.
Complications
The subsidence of the femoral stem was considered one of the most common risks for re‐revision 44 . Moreover, the design of modular stems is commonly accompanied by early subsidence 45 . Van Houwelingen et al. demonstrated that six out of 48 (12.5%) cases of substantial stem subsidence (>5 mm) happened with a mean subsidence of 12.3 mm and achieved stability during the first year after RTHA 45 . Abdel et al. showed that 12 (2.4%) patients underwent stem subsidence >5 mm, and one of them exhibited progressive subsidence 46 . In our study, the average subsidence of the stem was 3.9 mm (range, 1 to 10), and six out of 34 (18%) cases subsided over 5 mm, which was higher than that in a previous study and met the features of the modular stem. Additionally, early weight‐bearing and lower bone mass and quality might trigger stem subsidence in our study. However, no stem demonstrated progressive subsidence 1 year postoperatively. The risk of increased subsidence was affected by several factors. First, inappropriate and undersized stem diameter was found to be the key factor for progressive subsidence; therefore, the choice of a larger stem size and an increased 1–2 reamer size was suggested 44 . Second, the MP stem was designed with a 3° bow that accommodated the canal filling to provide better initial stability 40 . Moreover, the assistance of intraoperative fluoroscopy could help surgeons evaluate endosteal contact and implant position to avoid progressive subsidence.
Dislocation was another severe complication after RTHA. A high rate of dislocation was related to low femoral offset and deficient soft tissue. Weiss et al. showed that 17 (19%) dislocations occurred after RTHA within a minimum of 5 years of follow‐up 39 . Wang et al. indicated that two of 58 (3.4%) hips dislocated after RTHA and that one patient needed further re‐revision 25 . In our study, the number of dislocation cases was one (2.9%), which was lower than that in a previous study. The low rate of dislocation might be attributed to the modular design of the implant, which permitted adjustments of version and offset, good protection of the hip abductor mechanism during the surgical procedures, and use of the largest possible head size.
Survivorship
Modular junction fracture has been regarded as a potential risk for the design of modular stems. Several studies have already reported such a situation. Lakstein et al. revealed that six out of 165 (3.6%) stems had a fracture at the junction of the modular implant 47 . The analysis of risk factors including excessive body weight, inadequate bone support, osteolysis, loosening, and undersized prostheses were reported to lead to junction fracture. Van Houwelingen et al. demonstrated that five out of 48 (10.4%) patients experienced stem fracture of the modular junction with the standard ZMR® design 45 . The poor proximal femoral bone stock was identified as the vital factor for junction fracture in this study. Notably, Rodriguez et al. recorded one fractured stem in a Paprosky type IIIB patient 40 . The heavy weight and inappropriate size of the stem contributed to stem fracture. In our study, no case of junction fracture was observed, which might be due to the good bone reconstruction around the femoral proximal canal at the modular junction followed by adequate diaphyseal fit and no excessive BMI of patients, therefore indicating the long‐term survivorship of the modular stem under adequate bone reconstruction.
Limitations of the Study
There were some limitations of our study. First, our study was a retrospective study, which means that bias related to review and data was unavoidable, although we attempted to review each record precisely and objectively. Further prospective randomized controlled trials are essential. Second, the number of cohorts for RTHA with extensive bone loss was still not large enough, which might decrease the incidence of complications. Moreover, this study focused on only one type of stem without comparison to other alternative prostheses for massive femoral bone loss RTHA, which might be accompanied by selection bias. Finally, this was a single‐centre study, and all operations were performed by a single surgeon. Future multicentre design with a large cohort is needed for further investigation.
Conclusions
The mid‐ to long‐term outcomes of revision total hip arthroplasty with the cementless modular, fluted, tapered stem are inspiring for massive proximal femoral bone defects.
Contributor Information
Jun Zhou, Email: royf1@163.com.
Dechun Geng, Email: szgengdc@suda.edu.cn.
References
- 1. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am, 2009, 91: 128–133. [DOI] [PubMed] [Google Scholar]
- 2. Nemes S, Gordon M, Rogmark C, Rolfson O. Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop, 2014, 85: 238–243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am, 2007, 89: 780–785. [DOI] [PubMed] [Google Scholar]
- 4. Hooper G, Lee AJ, Rothwell A, Frampton C. Current trends and projections in the utilisation rates of hip and knee replacement in New Zealand from 2001 to 2026. N Z Med J, 2014, 127: 82–93. [PubMed] [Google Scholar]
- 5. Patel A, Pavlou G, Mujica‐Mota RE, Toms AD. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J, 2015, 97‐B: 1076–1081. [DOI] [PubMed] [Google Scholar]
- 6. Pivec R, Johnson AJ, Mears SC, Mont MA. Hip arthroplasty. Lancet, 2012, 380: 1768–1777. [DOI] [PubMed] [Google Scholar]
- 7. Iannotti JP, Balderston RA, Booth RE, Rothman RH, Cohn JC, Pickens G. Aseptic loosening after total hip arthroplasty. Incidence, clinical significance, and etiology. J Arthroplasty, 1986, 1: 99–107. [DOI] [PubMed] [Google Scholar]
- 8. Kurcz B, Lyons J, Sayeed Z, Anoushiravani AA, Iorio R. Osteolysis as it pertains to Total hip Arthroplasty. Orthop Clin North Am, 2018, 49: 419–435. [DOI] [PubMed] [Google Scholar]
- 9. Harrison T, Wynn Jones H, Darrah C, Warriner G, Tucker JK. Long stem cemented revision arthroplasty for aseptic loosening in elderly patients produces good results, despite significant bone loss. Hip Int, 2013, 23: 54–59. [DOI] [PubMed] [Google Scholar]
- 10. Makani A, Kim TW, Kamath AF, Garino JP, Lee GC. Outcomes of long tapered hydroxyapatite‐coated stems in revision total hip arthroplasty. J Arthroplasty, 2014, 29: 827–830. [DOI] [PubMed] [Google Scholar]
- 11. Revision Total Hip Arthroplasty Study Group . A comparison of modular tapered versus modular cylindrical stems for complex femoral revisions. J Arthroplasty, 2013, 28: 71–73. [DOI] [PubMed] [Google Scholar]
- 12. Chung LH, Wu PK, Chen CF, Chen WM, Chen TH, Liu CL. Extensively porous‐coated stems for femoral revision: reliable choice for stem revision in Paprosky femoral type III defects. Orthopedics, 2012, 35: e1017–e1021. [DOI] [PubMed] [Google Scholar]
- 13. Herry Y, Viste A, Bothorel H, Desmarchelier R, Fessy MH. Long‐term survivorship of a monoblock long cementless stem in revision total hip arthroplasty. Int Orthop, 2019, 43: 2279–2284. [DOI] [PubMed] [Google Scholar]
- 14. Lamberton TD, Kenny PJ, Whitehouse SL, Timperley AJ, Gie GA. Femoral impaction grafting in revision total hip arthroplasty: a follow‐up of 540 hips. J Arthroplasty, 2011, 26: 1154–1160. [DOI] [PubMed] [Google Scholar]
- 15. Haydon CM, Mehin R, Burnett S, et al. Revision total hip arthroplasty with use of a cemented femoral component. Results at a mean of ten years. J Bone Joint Surg Am, 2004, 86: 1179–1185. [DOI] [PubMed] [Google Scholar]
- 16. Engh CA Jr, Young AM, Engh CA Sr, Hopper RH Jr. Clinical consequences of stress shielding after porous‐coated total hip arthroplasty. Clin Orthop Relat Res, 2003, 417: 157–163. [DOI] [PubMed] [Google Scholar]
- 17. Sheth NP, Nelson CL, Paprosky WG. Femoral bone loss in revision total hip arthroplasty: evaluation and management. J Am Acad Orthop Surg, 2013, 21: 601–612. [DOI] [PubMed] [Google Scholar]
- 18. Brown NM, Tetreault M, Cipriano CA, Della Valle CJ, Paprosky W, Sporer S. Modular tapered implants for severe femoral bone loss in THA: reliable osseointegration but frequent complications. Clin Orthop Relat Res, 2015, 473: 555–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Palumbo BT, Morrison KL, Baumgarten AS, Stein MI, Haidukewych GJ, Bernasek TL. Results of revision total hip arthroplasty with modular, titanium‐tapered femoral stems in severe proximal metaphyseal and diaphyseal bone loss. J Arthroplasty, 2013, 28: 690–694. [DOI] [PubMed] [Google Scholar]
- 20. Spitzer AI. The S‐ROM cementless femoral stem: history and literature review. Orthopedics, 2005, 28: s1117–s1124. [DOI] [PubMed] [Google Scholar]
- 21. Shah RR, Goldstein JM, Cipparrone NE, Gordon AC, Jimenez ML, Goldstein WM. Alarmingly high rate of implant fractures in one modular femoral stem design: a comparison of two implants. J Arthroplasty, 2017, 32: 3157–3162. [DOI] [PubMed] [Google Scholar]
- 22. Konan S, Garbuz DS, Masri BA, Duncan CP. Modular tapered titanium stems in revision arthroplasty of the hip: the risk and causes of stem fracture. Bone Joint J, 2016, 98‐B: 50–53. [DOI] [PubMed] [Google Scholar]
- 23. Jang HG, Lee KJ, Min BW, Ye HU, Lim KH. Mid‐term results of revision total hip Arthroplasty using modular cementless femoral stems. Hip Pelvis, 2015, 27: 135–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ovesen O, Emmeluth C, Hofbauer C, Overgaard S. Revision total hip arthroplasty using a modular tapered stem with distal fixation: good short‐term results in 125 revisions. J Arthroplasty, 2010, 25: 348–354. [DOI] [PubMed] [Google Scholar]
- 25. Wang L, Dai Z, Wen T, Li M, Hu Y. Three to seven year follow‐up of a tapered modular femoral prosthesis in revision total hip arthroplasty. Arch Orthop Trauma Surg, 2013, 133: 275–281. [DOI] [PubMed] [Google Scholar]
- 26. Ibrahim DA, Fernando ND. Classifications in brief: the Paprosky classification of femoral bone loss. Clin Orthop Relat Res, 2017, 475: 917–921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Masri BA, Meek RM, Duncan CP. Periprosthetic fractures evaluation and treatment. Clin Orthop Relat Res, 2004, 420: 80–95. [DOI] [PubMed] [Google Scholar]
- 28. Della Valle CJ, Berger RA, Rosenberg AG, Jacobs JJ, Sheinkop MB, Paprosky WG. Extended trochanteric osteotomy in complex primary total hip arthroplasty. A brief note. J Bone Joint Surg Am, 2003, 85: 2385–2390. [DOI] [PubMed] [Google Scholar]
- 29. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg, 2002, 183: 630–641. [DOI] [PubMed] [Google Scholar]
- 30. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end‐result study using a new method of result evaluation. J Bone Joint Surg Am, 1969, 51: 737–755. [PubMed] [Google Scholar]
- 31. Myles PS, Myles DB, Galagher W, et al. Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. Br J Anaesth, 2017, 118: 424–429. [DOI] [PubMed] [Google Scholar]
- 32. Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous‐surfaced femoral components. Clin Orthop Relat Res, 1990, 257: 107–128. [PubMed] [Google Scholar]
- 33. Evola FR, Evola G, Graceffa A, et al. Performance of the CLS Spotorno uncemented stem in the third decade after implantation. Bone Joint J, 2014, 96‐B: 455–461. [DOI] [PubMed] [Google Scholar]
- 34. Sporer SM, Paprosky WG. Femoral fixation in the face of considerable bone loss: the use of modular stems. Clin Orthop Relat Res, 2004, 429: 227–231. [DOI] [PubMed] [Google Scholar]
- 35. Kusano T, Seki T, Higuchi Y, Takegami Y, Osawa Y, Ishiguro N. Preoperative Canal bone ratio is related to high‐degree stress shielding: a minimum 5‐year follow‐up study of a proximally hydroxyapatite‐coated straight tapered titanium femoral component. J Arthroplasty, 2018, 33: 1764–1769. [DOI] [PubMed] [Google Scholar]
- 36. Fink B, Grossmann A, Schubring S, Schulz MS, Fuerst M. A modified transfemoral approach using modular cementless revision stems. Clin Orthop Relat Res, 2007, 462: 105–114. [DOI] [PubMed] [Google Scholar]
- 37. Baktir A, Karaaslan F, Gencer K, Karaoglu S. Femoral revision using the Wagner SL revision stem: a single‐surgeon experience featuring 11‐19 years of follow‐up. J Arthroplasty, 2015, 30: 827–834. [DOI] [PubMed] [Google Scholar]
- 38. Restrepo C, Mashadi M, Parvizi J, Austin MS, Hozack WJ. Modular femoral stems for revision total hip arthroplasty. Clin Orthop Relat Res, 2011, 469: 476–482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Weiss RJ, Beckman MO, Enocson A, Schmalholz A, Stark A. Minimum 5‐year follow‐up of a cementless, modular, tapered stem in hip revision arthroplasty. J Arthroplasty, 2011, 26: 16–23. [DOI] [PubMed] [Google Scholar]
- 40. Rodriguez JA, Fada R, Murphy SB, Rasquinha VJ, Ranawat CS. Two‐year to five‐year follow‐up of femoral defects in femoral revision treated with the link MP modular stem. J Arthroplasty, 2009, 24: 751–758. [DOI] [PubMed] [Google Scholar]
- 41. Friberg O. Clinical symptoms and biomechanics of lumbar spine and hip joint in leg length inequality. Spine (Phila Pa 1976), 1983, 8: 643–651. [DOI] [PubMed] [Google Scholar]
- 42. Rosler J, Perka C. The effect of anatomical positional relationships on kinetic parameters after total hip replacement. Int Orthop, 2000, 24: 23–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Park YS, Moon YW, Lim SJ. Revision total hip arthroplasty using a fluted and tapered modular distal fixation stem with and without extended trochanteric osteotomy. J Arthroplasty, 2007, 22: 993–999. [DOI] [PubMed] [Google Scholar]
- 44. Patel PD, Klika AK, Murray TG, Elsharkawy KA, Krebs VE, Barsoum WK. Influence of technique with distally fixed modular stems in revision total hip arthroplasty. J Arthroplasty, 2010, 25: 926–931. [DOI] [PubMed] [Google Scholar]
- 45. Van Houwelingen AP, Duncan CP, Masri BA, Greidanus NV, Garbuz DS. High survival of modular tapered stems for proximal femoral bone defects at 5 to 10 years followup. Clin Orthop Relat Res, 2013, 471: 454–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Abdel MP, Cottino U, Larson DR, Hanssen AD, Lewallen DG, Berry DJ. Modular fluted tapered stems in aseptic revision total hip arthroplasty. J Bone Joint Surg Am, 2017, 99: 873–881. [DOI] [PubMed] [Google Scholar]
- 47. Lakstein D, Eliaz N, Levi O, et al. Fracture of cementless femoral stems at the mid‐stem junction in modular revision hip arthroplasty systems. J Bone Joint Surg Am, 2011, 93: 57–65. [DOI] [PubMed] [Google Scholar]
